977 related articles for article (PubMed ID: 24184386)
1. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.
Manjavachi MN; Costa R; Quintão NL; Calixto JB
Neuropharmacology; 2014 Apr; 79():17-27. PubMed ID: 24184386
[TBL] [Abstract][Full Text] [Related]
2. The effects of the selective and non-peptide CXCR2 receptor antagonist SB225002 on acute and long-lasting models of nociception in mice.
Manjavachi MN; Quintão NL; Campos MM; Deschamps IK; Yunes RA; Nunes RJ; Leal PC; Calixto JB
Eur J Pain; 2010 Jan; 14(1):23-31. PubMed ID: 19264522
[TBL] [Abstract][Full Text] [Related]
3. CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury.
Saika F; Kiguchi N; Kobayashi Y; Fukazawa Y; Kishioka S
Eur J Pain; 2012 Oct; 16(9):1271-80. PubMed ID: 22528550
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic augmentation of the macrophage inflammatory protein 2/C-X-C chemokine receptor type 2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain.
Kiguchi N; Kobayashi Y; Maeda T; Fukazawa Y; Tohya K; Kimura M; Kishioka S
J Pharmacol Exp Ther; 2012 Mar; 340(3):577-87. PubMed ID: 22135382
[TBL] [Abstract][Full Text] [Related]
5. PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.
Guida F; Lattanzi R; Boccella S; Maftei D; Romano R; Marconi V; Balboni G; Salvadori S; Scafuro MA; de Novellis V; Negri L; Maione S; Luongo L
Pharmacol Res; 2015 Jan; 91():36-46. PubMed ID: 25434589
[TBL] [Abstract][Full Text] [Related]
6. Spinal CXCL5 contributes to nerve injury-induced neuropathic pain via modulating GSK-3β phosphorylation and activity in rats.
Xu W; Zhu M; Yuan S; Yu W
Neurosci Lett; 2016 Nov; 634():52-59. PubMed ID: 27717828
[TBL] [Abstract][Full Text] [Related]
7. CC-chemokine MIP-1α in the spinal cord contributes to nerve injury-induced neuropathic pain.
Kiguchi N; Kobayashi Y; Maeda T; Saika F; Kishioka S
Neurosci Lett; 2010 Oct; 484(1):17-21. PubMed ID: 20692319
[TBL] [Abstract][Full Text] [Related]
8. Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.
Takasu K; Honda M; Ono H; Tanabe M
Br J Pharmacol; 2006 May; 148(2):233-44. PubMed ID: 16582934
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain.
Imai S; Ikegami D; Yamashita A; Shimizu T; Narita M; Niikura K; Furuya M; Kobayashi Y; Miyashita K; Okutsu D; Kato A; Nakamura A; Araki A; Omi K; Nakamura M; James Okano H; Okano H; Ando T; Takeshima H; Ushijima T; Kuzumaki N; Suzuki T; Narita M
Brain; 2013 Mar; 136(Pt 3):828-43. PubMed ID: 23364351
[TBL] [Abstract][Full Text] [Related]
10. Chemical composition and evaluation of the anti-hypernociceptive effect of the essential oil extracted from the leaves of Ugni myricoides on inflammatory and neuropathic models of pain in mice.
Quintão NL; da Silva GF; Antonialli CS; Rocha LW; Cechinel Filho V; Cicció JF
Planta Med; 2010 Sep; 76(13):1411-8. PubMed ID: 20157878
[TBL] [Abstract][Full Text] [Related]
11. Oral gabapentin treatment accentuates nerve and peripheral inflammatory responses following experimental nerve constriction in Wistar rats.
Câmara CC; Ramos HF; da Silva AP; Araújo CV; Gomes AS; Vale ML; Barbosa AL; Ribeiro RA; Brito GA; Costa CM; Oriá RB
Neurosci Lett; 2013 Nov; 556():93-8. PubMed ID: 24140003
[TBL] [Abstract][Full Text] [Related]
12. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive synergism of gabapentin and nortriptyline in mice with partial sciatic nerve ligation.
Miranda HF; Noriega V; Zepeda R; Zanetta P; Prieto-Rayo J; Prieto JC; Sierralta F
Pharmacology; 2015; 95(1-2):59-64. PubMed ID: 25592638
[TBL] [Abstract][Full Text] [Related]
14. The critical role of spinal ceramide in the development of partial sciatic nerve ligation-induced neuropathic pain in mice.
Kobayashi Y; Kiguchi N; Maeda T; Ozaki M; Kishioka S
Biochem Biophys Res Commun; 2012 May; 421(2):318-22. PubMed ID: 22503971
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1β overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents.
Gui WS; Wei X; Mai CL; Murugan M; Wu LJ; Xin WJ; Zhou LJ; Liu XG
Mol Pain; 2016; 12():. PubMed ID: 27175012
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 levels in rat models of nerve damage and neuropathic pain.
Khan J; Ramadan K; Korczeniewska O; Anwer MM; Benoliel R; Eliav E
Neurosci Lett; 2015 Apr; 592():99-106. PubMed ID: 25757362
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats.
Guneli E; Onal A; Ates M; Bagriyanik HA; Resmi H; Orhan CE; Kolatan HE; Gumustekin M
Neurosci Lett; 2010 Aug; 479(3):226-30. PubMed ID: 20561937
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: Evidence for the mechanisms of action.
Nucci-Martins C; Martins DF; Nascimento LF; Venzke D; Oliveira AS; Frederico MJ; Silva FR; Brighente IM; Pizzolatti MG; Santos AR
J Ethnopharmacol; 2015 Dec; 175():273-86. PubMed ID: 26386380
[TBL] [Abstract][Full Text] [Related]
19. Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model.
He WJ; Cui J; Du L; Zhao YD; Burnstock G; Zhou HD; Ruan HZ
Behav Brain Res; 2012 Jan; 226(1):163-70. PubMed ID: 21933684
[TBL] [Abstract][Full Text] [Related]
20. Nrf2/HO-1 signaling pathway participated in the protection of hydrogen sulfide on neuropathic pain in rats.
Chen H; Xie K; Chen Y; Wang Y; Wang Y; Lian N; Zhang K; Yu Y
Int Immunopharmacol; 2019 Oct; 75():105746. PubMed ID: 31325725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
